As respiratory syncytial virus (RSV) vaccine distribution gains traction in Europe and Italy,
healthcare workers (HCWs) can strategize about vaccine promotion to increase uptake …

abstract Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in
adults, particularly older adults and those with underlying medical conditions. Vaccination …

RSV infection causes severe respiratory illness and mortality in the elderly, especially in the
presence of comorbidities. Early identification of infection would result in appropriate …

Globally, respiratory syncytial virus (RSV) is a leading cause of respiratory infections and is
responsible for a significant socioeconomic burden in all age groups, including adults. To …

Background: This study was conducted to assess parents' willingness to vaccinate their
children with the RSV vaccine and the key predictors of this intention among parents in Italy …

Respiratory syncytial virus (RSV) poses a significant burden on public health, causing lower
respiratory tract infections in infants, young children, older adults, and immunocompromised …

Respiratory Syncytial Virus (RSV) is associated with most of the acute viral respiratory tract
infections causing hospitalization with a peak during the first months of life. Many clinical …

Objective: To explore whether RSV vaccines are efficacious in preventing respiratory
syncytial virus (RSV) lower respiratory infection (LRI). Methods: Randomized clinical trials …

Objectives To determine the efficacy and safety of respiratory syncytial virus (RSV) vaccines
in infants and older adults. Methods We performed a systematic review and meta-analysis of …

Respiratory syncytial virus (RSV) inflicts severe illness and courses of infections not only in
neonates, infants, and young children, but also causes significant morbidity and mortality in …